GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Nova Pharma Solutions Bhd (XKLS:03006) » Definitions » 3-Year Book Growth Rate

Nova Pharma Solutions Bhd (XKLS:03006) 3-Year Book Growth Rate : 13.30% (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Nova Pharma Solutions Bhd 3-Year Book Growth Rate?

Nova Pharma Solutions Bhd's Book Value per Share for the quarter that ended in Dec. 2023 was RM0.10.

During the past 12 months, Nova Pharma Solutions Bhd's average Book Value per Share Growth Rate was 28.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was 13.30% per year. During the past 5 years, the average Book Value per Share Growth Rate was 5.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 9 years, the highest 3-Year average Book Value per Share Growth Rate of Nova Pharma Solutions Bhd was 77.40% per year. The lowest was 1.00% per year. And the median was 12.65% per year.


Competitive Comparison of Nova Pharma Solutions Bhd's 3-Year Book Growth Rate

For the Engineering & Construction subindustry, Nova Pharma Solutions Bhd's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nova Pharma Solutions Bhd's 3-Year Book Growth Rate Distribution in the Construction Industry

For the Construction industry and Industrials sector, Nova Pharma Solutions Bhd's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Nova Pharma Solutions Bhd's 3-Year Book Growth Rate falls into.



Nova Pharma Solutions Bhd 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Nova Pharma Solutions Bhd  (XKLS:03006) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Nova Pharma Solutions Bhd 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Nova Pharma Solutions Bhd's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Nova Pharma Solutions Bhd (XKLS:03006) Business Description

Traded in Other Exchanges
N/A
Address
Jalan USJ 25/1, Level 5, Suite C-5-1 & 2, Block C, Sky Park, One City, Subang Jaya, SGR, MYS, 47650
Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.

Nova Pharma Solutions Bhd (XKLS:03006) Headlines

No Headlines